For this first-time visitor, the Naga capital city unfolded like a cold night’s dream offering stories of history, culture, ...

Dr. Reddy's launches Loqtorzi biosimilar in India under the brand name Zytorvi for treating adults with recurrent or ...

The Government of India is making continuous efforts to promote IT industry in smaller cities and towns and has initiated multiple schemes and programmes for growth of IT industry in this regard. The ...

Dr. Reddy’s will market it under the brand name Zytorvi in India ... The highest age-adjusted rates for NPC were found in the ...

Dr. Reddy’s Laboratories on Thursday announced the launch of Toripalimab in India to treat adults with Nasopharyngeal ...

American scholar Eric Zency who uses the principles of ecological economics has come up with a model he called the Genuine Progress Indicator (GPI) which he says needs to replace the GDP. And looking ...

With this launch, India has become the third country in the world, after China and the US, to receive access to this ...

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as "Dr. Reddy's"), announced the launch of Toripalimab in India.

Dr Reddy's launches toripalimab in India for the treatment of nasopharyngeal carcinoma: Our Bureau, Bengaluru Thursday, November 28, 2024, 12:15 Hrs [IST] Dr Reddy’s Laboratorie ...

Dr. Reddy's Laboratories has announced the launch of Toripalimab in India. This drug is designed to treat adults suffering ...